$26.76
-0.32-1.18%
At Close: -
$26.76
00.00%
After Hours: Jul 19, 5:07 PM EDT
15 minutes delayed
Comments
Loading...
Akero Therapeutics
AKRONASDAQ
Akero Therapeutics (AKRO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestAkero Therapeutics (NASDAQ:AKRO) Stock Quotes, Forecast and News Summary
Akero Therapeutics Stock (NASDAQ: AKRO) stock price, news, charts, stock research, profile.
| Open | $27.14 |
| Close | $26.76 |
| Volume / Avg. | 686.99K / 810.76K |
| Day Range | 26.28 - 27.41 |
| 52 Wk Range | 11.25 - 53.77 |
| Market Cap | $1.85B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 66 |
| Short Interest | 9.63% |
| Days to Cover | 5.47 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Akero Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercia...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Akero Therapeutics (AKRO) stock?
You can purchase shares of Akero Therapeutics (NASDAQ:AKRO) through any online brokerage.
Who are Akero Therapeutics (AKRO) competitors?
Other companies in Akero Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Protagonist Therapeutics (NASDAQ:PTGX), Kiniksa Pharmaceuticals (NASDAQ:KNSA), Bicycle Therapeutics (NASDAQ:BCYC) and BioCryst Pharma (NASDAQ:BCRX).
What is the target price for Akero Therapeutics (AKRO) stock?
There is no analysis for Akero Therapeutics.
What is the forecast for Akero Therapeutics (AKRO) stock?
Akero Therapeutics has a consensus price target of $39.90.
Current stock price for Akero Therapeutics (AKRO)?
The stock price for Akero Therapeutics (NASDAQ: AKRO) is $26.76 last updated July 19, 2024 at 5:07 PM EDT.
Does Akero Therapeutics (AKRO) pay a dividend?
There are no upcoming dividends for Akero Therapeutics.
When is Akero Therapeutics (NASDAQ:AKRO) reporting earnings?
Akero Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
Is Akero Therapeutics (AKRO) going to split?
There is no upcoming split for Akero Therapeutics.
What sector and industry does Akero Therapeutics (AKRO) operate in?
Akero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.